These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17483062)

  • 1. Quantification of circulating varicella-zoster virus DNA for follow-up in a case of visceral varicella-zoster infection ameliorated with intravenous acyclovir.
    Ishizawa J; Fujita H; Iguchi M; Tachibana T; Taguchi J; Ishigatsubo Y
    Int J Hematol; 2007 Apr; 85(3):242-5. PubMed ID: 17483062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella-zoster virus encephalitis in a patient undergoing unrelated cord blood transplantation for myelodysplastic syndrome-overt leukemia.
    Fukuno K; Tomonari A; Takahashi S; Ooi J; Takasugi K; Tsukada N; Konuma T; Iseki T; Moriwaki H; Tojo A; Asano S
    Int J Hematol; 2006 Jul; 84(1):79-82. PubMed ID: 16867908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient.
    Tauro S; Toh V; Osman H; Mahendra P
    Bone Marrow Transplant; 2000 Oct; 26(7):795-6. PubMed ID: 11042663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of circulating varicella zoster virus-DNA for the early diagnosis of visceral varicella.
    Ishizaki Y; Tezuka J; Ohga S; Nomura A; Suga N; Kuromaru R; Kusuhara K; Mizuno Y; Kasuga N; Hara T
    J Infect; 2003 Aug; 47(2):133-8. PubMed ID: 12860147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyclovir treatment of varicella-zoster virus meningeal infections and acute kidney injury: a multicentre case series study.
    Contamine M; Ader F; Lepiller Q; Martha B; Cagnon-Chapalain J; Leturnier P; Frober E; Bouiller K; Binquet C; Auvray C; Piroth L; Blot M
    Infect Dis (Lond); 2024 Oct; 56(10):842-850. PubMed ID: 38822453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral therapy for varicella and herpes zoster.
    Arvin AM
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):12-21. PubMed ID: 12118839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral acyclovir in varicella zoster virus infections in children with acute lymphoblastic leukemia.
    Jain Y; Lodha R; Tomar S; Arya LS; Kabra SK
    Indian Pediatr; 2000 Nov; 37(11):1239-41. PubMed ID: 11086306
    [No Abstract]   [Full Text] [Related]  

  • 9. Acyclovir therapy of varicella-zoster virus infections in immunocompromised patients.
    Balfour HH; McMonigal KA; Bean B
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():169-79. PubMed ID: 6313596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Kanda Y; Mineishi S; Saito T; Saito A; Yamada S; Ohnishi M; Chizuka A; Niiya H; Suenaga K; Nakai K; Takeuchi T; Makimoto A; Tanosaki R; Kami M; Tanaka Y; Fujita S; Watanabe T; Kobayashi Y; Tobinai K; Takaue Y
    Bone Marrow Transplant; 2001 Oct; 28(7):689-92. PubMed ID: 11704792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of acyclovir susceptibility and genetic stability of varicella-zoster viruses isolated during acyclovir therapy.
    Ida M; Kageyama S; Sato H; Kamiyama T; Toyomoto T; Ozaki T; Kajita Y; Morohashi M; Shiraki K
    J Dermatol Sci; 2000 May; 23(1):63-72. PubMed ID: 10699766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.
    Asano-Mori Y; Kanda Y; Oshima K; Kako S; Shinohara A; Nakasone H; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2008 Jun; 83(6):472-6. PubMed ID: 18266207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triad of severe abdominal pain, inappropriate antidiuretic hormone secretion, and disseminated varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic stem cell transplantation: utility of PCR for early recognition and therapy.
    Rau R; Fitzhugh CD; Baird K; Cortez KJ; Li L; Fischer SH; Cowen EW; Balow JE; Walsh TJ; Cohen JI; Wayne AS
    Pediatr Infect Dis J; 2008 Mar; 27(3):265-8. PubMed ID: 18277922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella-zoster virus retinitis: successful evolution with a combination of antiviral therapies.
    Oueghlani E; Baglivo E; Durakovic O; Safran AB
    Klin Monbl Augenheilkd; 2005 Mar; 222(3):264-6. PubMed ID: 15785997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyclovir treatment prevents varicella-zoster virus replication in PBMC during viremia.
    Wolff MH; Schünemann S
    New Microbiol; 1999 Oct; 22(4):309-14. PubMed ID: 10555200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral varicella zoster virus (VZV) after allogeneic hematopoietic stem cell transplant (HSCT) in pediatric patients with chronic graft-versus-host disease (cGVHD).
    Peritz DC; Duncan C; Kurek K; Perez-Atayde AR; Lehmann LE
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):931-4. PubMed ID: 19131784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral varicella zoster virus infection after allogeneic stem cell transplantation.
    Doki N; Miyawaki S; Tanaka M; Kudo D; Wake A; Oshima K; Fujita H; Uehara T; Hyo R; Mori T; Takahashi S; Okamoto S; Sakamaki H;
    Transpl Infect Dis; 2013 Jun; 15(3):314-8. PubMed ID: 23551634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation.
    Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura S; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
    Int J Infect Dis; 2014 Feb; 19():26-32. PubMed ID: 24211377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal foscarnet for the treatment of acyclovir-resistant acute retinal necrosis caused by varicella zoster virus.
    Lee MY; Kim KS; Lee WK
    Ocul Immunol Inflamm; 2011 Jun; 19(3):212-3. PubMed ID: 21595539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous erythema multiforme following herpes zoster and varicella-zoster virus infection.
    Weisman K; Petersen CS; Blichmann CW; Nielsen NH; Hultberg BM
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):147-50. PubMed ID: 9784041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.